We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Dentistry Approaching a Major New Treatment Breakthrough

By HospiMedica International staff writers
Posted on 13 Jul 2010
Print article
Image: Atomic force microscopy image of the multilayered PGA-alpha-MSH film (photo courtesy INSERM).
Image: Atomic force microscopy image of the multilayered PGA-alpha-MSH film (photo courtesy INSERM).
The next big treatment revolution in dentistry could involve a novel regenerative therapy in which diseased or necrotic pulp tissues are replaced with healthy pulp tissue to revitalize teeth, claims a new study.

Researchers at the Institut National de la Sante et de la Recherche Medicale (INSERM; Strasbourg, France), the University of Montpellier (France), and other institutions reported the development of a multilayered, nano-sized film--only 1/50,000th the thickness of a human hair--that contains alpha melanocyte stimulating hormone (α-MSH), a substance that possesses anti-inflammatory properties in many acute and chronic inflammatory models. When α-MSH was covalently coupled to poly-l-glutamic acid (PGA), the resulting PGA-α-MSH nanofilm retained its anti-inflammatory properties when tested on rat monocytes.

The researchers then incubated PGA-α-MSH with dental pulp lipopolysaccharide (LPS)-stimulated fibroblasts, and were able to show that PGA-α-MSH has potential effects in promoting human pulp fibroblast adhesion and cell proliferation. It can also reduce the inflammatory state of LPS-stimulated pulp fibroblasts, as observed in gram-negative bacterial infections. According to the researchers, these effects suggest a novel use of PGA-α-MSH as an anti-inflammatory agent in regenerative endodontics, the development and delivery of tissues to replace diseased or damaged dental pulp, and could provide a revolutionary alternative to pulp removal in root canal therapy (RCT). The study was reported in the July 2010 issue of the American Chemical Society (ACS) journal Nano.

"It's not like toothpaste, which prevents cavities,” said coauthor Nadia Benkirane-Jessel, Ph.D., of INSERM. "Here we are really trying to control cavities after they develop. Instead of a drill, a quick dab of gel or a thin film against an infected tooth could heal teeth from within.”

According to the researchers, PGA-α-MSH can not only modulate pro- and anti-inflammatory cytokines but can also promote adhesion of pulpal fibroblasts, and could therefore have important regulatory functions in extracellular matrix composition, as well as additional regulatory functions needed to modulate pulpal inflammation and reduce the need for RCT.

Related Links:

Institut National de la Sante et de la Recherche Medicale
University of Montpellier



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.